Tarveda Therapeutics
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Tarveda Therapeutics Information
Geographic Data
Address:
City: Watertown
State: Massachusetts
Zip:
Country: United States
Financial Info
Stage:
series unknown
Raised Last:
$6M
Raised Total:$148M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors. The company&s;s HSP90 targeted drug conjugate platform with lead drug candidate PEN-866 selectively binds in tumors to the activated form of Heat Shock Protein 90 (HSP90) and releases its potent topoisomerase 1 inhibitor payload, SN38 and it also develops a miniature drug conjugate in clinical evaluation for the treatment of patients with somatostatin receptor 2 (SSTR2) expressing neuroendocrine, small cell lung and other solid tumors, enabling companies to extend the lives of patients with hard to treat cancers while minimizing potential toxicities.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2021 | Venture Round | $6M | 12/2019 | Venture Round | $13.6M | 12/2020 | Venture Round | $15M | 1/2012 | Series A | 3 | $2.8M |
Flagship Pioneering NanoDimension New Enterprise Associates Flagship Pioneering NanoDimension New Enterprise Associates |
1/2016 | Series C | 2 | $38M |
New Enterprise Associates Novo Holdings Novo Holdings New Enterprise Associates Novo Holdings Novo Holdings |
3/2014 | Venture Round | $1M | 1/2015 | Series B | 4 | $21M |
New Enterprise Associates NanoDimension Eminent Venture Capital Flagship Pioneering New Enterprise Associates NanoDimension Eminent Venture Capital |
2/2017 | Series D | 5 | $30M |
Novo Holdings Versant Ventures New Enterprise Associates Flagship Pioneering NanoDimension Versant Ventures Novo Holdings Versant Ventures New Enterprise Associates Flagship Pioneering NanoDimension Versant Ventures |
12/2013 | Series B | 3 | $21M |
New Enterprise Associates NanoDimension Flagship Pioneering |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
